These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 30649327

  • 1. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    Ruth MM, Sangen JJN, Remmers K, Pennings LJ, Svensson E, Aarnoutse RE, Zweijpfenning SMH, Hoefsloot W, Kuipers S, Magis-Escurra C, Wertheim HFL, van Ingen J.
    J Antimicrob Chemother; 2019 Apr 01; 74(4):935-943. PubMed ID: 30649327
    [Abstract] [Full Text] [Related]

  • 2. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE, Meletiadis J, Wattenberg M, de Jong A, van Soolingen D, Mouton JW, van Ingen J.
    Antimicrob Agents Chemother; 2016 Feb 01; 60(2):1097-105. PubMed ID: 26643335
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.
    Richard M, Gutiérrez AV, Viljoen A, Rodriguez-Rincon D, Roquet-Baneres F, Blaise M, Everall I, Parkhill J, Floto RA, Kremer L.
    Antimicrob Agents Chemother; 2019 Jan 01; 63(1):. PubMed ID: 30323043
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.
    Gutiérrez AV, Richard M, Roquet-Banères F, Viljoen A, Kremer L.
    Antimicrob Agents Chemother; 2019 Oct 01; 63(10):. PubMed ID: 31332077
    [Abstract] [Full Text] [Related]

  • 7. In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China.
    Luo J, Yu X, Jiang G, Fu Y, Huo F, Ma Y, Wang F, Shang Y, Liang Q, Xue Y, Huang H.
    Antimicrob Agents Chemother; 2018 Jul 01; 62(7):. PubMed ID: 29760127
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of bedaquiline against Mycobacterium avium complex.
    Litvinov V, Makarova M, Kudlay D, Nikolenko N, Mikhailova J.
    J Med Microbiol; 2021 Oct 01; 70(10):. PubMed ID: 34668850
    [Abstract] [Full Text] [Related]

  • 10. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium abscessus Complex.
    Brown-Elliott BA, Wallace RJ.
    Antimicrob Agents Chemother; 2019 Feb 01; 63(2):. PubMed ID: 30509936
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
    Pang Y, Jing W, Lu J, Zong Z, Huo F, Dong L, Dai G, Li Y, Huang H, Chu N.
    Diagn Microbiol Infect Dis; 2019 Aug 01; 94(4):361-364. PubMed ID: 30876684
    [Abstract] [Full Text] [Related]

  • 14. In Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex.
    Brown-Elliott BA, Philley JV, Griffith DE, Thakkar F, Wallace RJ.
    Antimicrob Agents Chemother; 2017 Feb 01; 61(2):. PubMed ID: 27872065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
    Xu J, Wang B, Hu M, Huo F, Guo S, Jing W, Nuermberger E, Lu Y.
    Antimicrob Agents Chemother; 2017 Jun 01; 61(6):. PubMed ID: 28320727
    [Abstract] [Full Text] [Related]

  • 17. In Vitro Activity of Bedaquiline against Nontuberculous Mycobacteria in China.
    Pang Y, Zheng H, Tan Y, Song Y, Zhao Y.
    Antimicrob Agents Chemother; 2017 May 01; 61(5):. PubMed ID: 28242674
    [Abstract] [Full Text] [Related]

  • 18. Clofazimine Exposure In Vitro Selects Efflux Pump Mutants and Bedaquiline Resistance.
    Ismail N, Peters RPH, Ismail NA, Omar SV.
    Antimicrob Agents Chemother; 2019 Mar 01; 63(3):. PubMed ID: 30642938
    [Abstract] [Full Text] [Related]

  • 19. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ, Kim SY, Shim HJ, Kim DH, Yoo IY, Kang OK, Ki CS, Shin SY, Jhun BW, Shin SJ, Daley CL, Koh WJ, Lee NY.
    J Clin Microbiol; 2019 Aug 01; 57(8):. PubMed ID: 31167842
    [Abstract] [Full Text] [Related]

  • 20. Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.
    Li B, Ye M, Guo Q, Zhang Z, Yang S, Ma W, Yu F, Chu H.
    Antimicrob Agents Chemother; 2018 Jul 01; 62(7):. PubMed ID: 29712658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.